West Pharmaceutical Services Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$844,900	$805,000	$804,300	$766,200
Gross Profit	296,400	303,900	293,500	273,200
EBITDA	173,900	209,500	217,100	198,500
EBIT		162,500	174,100	157,100
Net Income	138,800	132,100	140,000	131,800
Net Change In Cash	844,900	805,000	804,300	766,200
Free Cash Flow	47,200	175,000	133,900	101,900
Cash	521,400	791,300	628,500	509,700
Basic Shares	72,400	72,700	72,700	72,800

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,073,700	$2,892,700	$2,951,100	$2,885,500
Gross Profit	1,103,300	1,002,200	1,132,700	1,138,900
EBITDA	723,600	743,800	844,100	808,100
EBIT	599,200	588,400	706,800	687,500
Net Income	493,700	492,700	593,400	585,900
Net Change In Cash	3,073,700	2,892,700	2,951,100	2,885,500
Cost of Revenue				142,200
Free Cash Flow	468,900	276,400	414,500	439,400
Cash	791,300	484,600	853,900	894,300
Basic Shares	72,700	73,700	75,300	75,800